{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T18:19:48Z","timestamp":1794939588090,"version":"4.9.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016658","name":"National Plan on Drugs","doi-asserted-by":"publisher","award":["PNSD 2022\/020"],"award-info":[{"award-number":["PNSD 2022\/020"]}],"id":[{"id":"10.13039\/100016658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["CTS-433"],"award-info":[{"award-number":["CTS-433"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["RD24\/0003\/0012"],"award-info":[{"award-number":["RD24\/0003\/0012"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI22\/01833"],"award-info":[{"award-number":["PI22\/01833"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["RD21\/0009\/0003"],"award-info":[{"award-number":["RD21\/0009\/0003"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI19\/00886"],"award-info":[{"award-number":["PI19\/00886"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI22\/00427"],"award-info":[{"award-number":["PI22\/00427"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI20\/01399"],"award-info":[{"award-number":["PI20\/01399"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI22\/01833"],"award-info":[{"award-number":["PI22\/01833"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI20\/01399"],"award-info":[{"award-number":["PI20\/01399"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["RD21\/0009\/0003"],"award-info":[{"award-number":["RD21\/0009\/0003"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI19\/00886"],"award-info":[{"award-number":["PI19\/00886"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI22\/00427"],"award-info":[{"award-number":["PI22\/00427"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["FORT23\/00013"],"award-info":[{"award-number":["FORT23\/00013"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002878","name":"Consejer\u00eda de Econom\u00eda, Innovaci\u00f3n, Ciencia y Empleo, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.pnpbp.2025.111350","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T13:41:32Z","timestamp":1743946892000},"page":"111350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Exploratory study on plasma Acylglycerol and Acylethanolamide dysregulation in substance use and attention-deficit\/hyperactivity disorder: Implications for novel biomarkers in dual diagnosis"],"prefix":"10.1016","volume":"138","author":[{"given":"Mar\u00eda","family":"Flores-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Herrera-Imbroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Requena-Oca\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Garc\u00eda-Marchena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Araos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Verheul-Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jes\u00fas","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Bordallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"Pav\u00f3n-Mor\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Rodr\u00edguez de Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pnpbp.2025.111350_bb0005","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.ygeno.2019.07.024","article-title":"The first evidence of an association between a polymorphism in the endocannabinoid-degrading enzyme FAAH (FAAH rs2295633) with attention deficit hyperactivity disorder","volume":"112","author":"Ahmadalipour","year":"2020","journal-title":"Genomics"},{"key":"10.1016\/j.pnpbp.2025.111350_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115194","article-title":"The FAAH inhibitor URB597 reduces cocaine intake during conditioned punishment and mitigates cocaine seeking during withdrawal","volume":"165","author":"Alegre-Zurano","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111350_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-50426-4","article-title":"Sex-dimorphism in human serum endocannabinoid and n-acyl ethanolamine concentrations across the lifespan","volume":"13","author":"Amir Hamzah","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2025.111350_bb0020","series-title":"DSM-5: Manual Diagn\u00f3stico y Estad\u00edstico de los Trastornos Mentales (s. f.)","author":"APA","year":"2014"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111350_bb0025","first-page":"417","article-title":"Prevalencia del d\u00e9ficit de atenci\u00f3n e hiperactividad en personas adultas seg\u00fan el registro de las historias cl\u00ednicas informatizadas de atenci\u00f3n primaria","volume":"84","author":"Aragon\u00e8s","year":"2010","journal-title":"Rev. Esp. Salud Publ."},{"issue":"10","key":"10.1016\/j.pnpbp.2025.111350_bb0030","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1007\/s00213-024-06683-w","article-title":"Emerging roles of cannabinoid receptor CB2 receptor in the central nervous system: therapeutic target for CNS disorders","volume":"241","author":"Bala","year":"2024","journal-title":"Psychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2025.111350_bb0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0014-2999(03)01557-7","article-title":"Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons","volume":"466","author":"Basavarajappa","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111350_bb0040","doi-asserted-by":"crossref","first-page":"395","DOI":"10.31887\/DCNS.2016.18.4\/jbecker","article-title":"Sex differences in addiction","volume":"18","author":"Becker","year":"2016","journal-title":"Dialogues Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111350_bb0045","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.biopsych.2022.11.022","article-title":"Association between fatty acid amide hydrolase and alcohol response phenotypes: a positron emission tomography imaging study with [11C]CURB in heavy-drinking youth","volume":"94","author":"Best","year":"2023","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111350_bb0050","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/adb.12006","article-title":"Oleoylethanolamide dose-dependently attenuates cocaine-induced behaviours through a PPAR\u03b1 receptor-independent mechanism","volume":"18","author":"Bilbao","year":"2013","journal-title":"Addict. Biol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111350_bb0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00213-011-2446-6","article-title":"Attenuation of cocaine-induced conditioned locomotion is associated with altered expression of hippocampal glutamate receptors in mice lacking LPA1 receptors","volume":"220","author":"Blanco","year":"2012","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111350_bb0060","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu024","article-title":"Cocaine-induced behavioral sensitization is associated with changes in the expression of endocannabinoid and glutamatergic signaling systems in the mouse prefrontal cortex","volume":"18","author":"Blanco","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111350_bb0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/15504263.2021.1944711","article-title":"Impulsive personality traits mediate the relationship between attention-deficit\/hyperactivity disorder symptoms and psychiatric comorbidity among patients with severe alcohol use disorder","volume":"17","author":"Brandt","year":"2021","journal-title":"J. Dual Diagn."},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111350_bb0070","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3390\/biomedicines9091173","article-title":"Sphingolipid and endocannabinoid profiles in adult attention deficit hyperactivity disorder","volume":"9","author":"Brunkhorst-Kanaan","year":"2021","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111350_bb0075","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.neuroimage.2010.12.028","article-title":"Penalized least squares regression methods and applications to neuroimaging","volume":"55","author":"Bunea","year":"2011","journal-title":"NeuroImage"},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111350_bb0080","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1089\/brain.2022.0076","article-title":"Neurobiological dysfunctional substrates for the self-medication hypothesis in adult individuals with attention-deficit hyperactivity disorder and cocaine use disorder: a Fluorine-18-Fluorodeoxyglucose positron emission tomography study","volume":"13","author":"Carli","year":"2023","journal-title":"Brain Connect."},{"issue":"17","key":"10.1016\/j.pnpbp.2025.111350_bb0085","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1212\/WNL.0b013e3181a2e8f6","article-title":"Altered anandamide degradation in attention-deficit\/hyperactivity disorder","volume":"72","author":"Centonze","year":"2009","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111350_bb0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/ijms25073603","article-title":"Cannabinoids and sleep: exploring biological mechanisms and therapeutic potentials","volume":"25","author":"D\u2019Angelo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2025.111350_bb0095","first-page":"205","article-title":"Features and prevalence of patients with probable adult attention deficit hyperactivity disorder who request treatment for cocaine use disorders","volume":"185","author":"de Los","year":"2011","journal-title":"Psychiatry Res."},{"issue":"5090","key":"10.1016\/j.pnpbp.2025.111350_bb0100","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2025.111350_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.20","article-title":"Attention-deficit\/hyperactivity disorder","volume":"1","author":"Faraone","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111350_bb0110","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3390\/biomedicines9091207","article-title":"Plasma concentrations of lysophosphatidic acid and Autotaxin in abstinent patients with alcohol use disorder and comorbid liver disease","volume":"9","author":"Flores-L\u00f3pez","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111350_bb0115","doi-asserted-by":"crossref","first-page":"8568","DOI":"10.1038\/s41598-022-10757-0","article-title":"Influence of diet on acute endocannabinoidome mediator levels post exercise in active women, a crossover randomized study","volume":"12","author":"Forteza","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111350_bb0120","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1186\/s12888-024-05986-8","article-title":"Peripheral endocannabinoids in major depressive disorder and alcohol use disorder: a systematic review","volume":"24","author":"Fuentes","year":"2024","journal-title":"BMC Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111350_bb0125","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.medcli.2023.11.016","article-title":"Substance use disorder: epidemiology, medical consequences and treatment","volume":"162","author":"Fuster","year":"2024","journal-title":"Med. Clin."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111350_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93075-1","article-title":"Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder","volume":"11","author":"Galv\u00e1n","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2025.111350_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2022.09.026","article-title":"The assessment of endocannabinoids and N-acylethanolamines in human hair: associations with sociodemographic and psychological variables","volume":"537","author":"Gao","year":"2022","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111350_bb0140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.20882\/adicciones.728","article-title":"Psychiatric comorbidity and plasma levels of 2-acyl-glycerols in outpatient treatment alcohol users. Analysis of gender differences","volume":"29","author":"Garc\u00eda Marchena","year":"2016","journal-title":"Adicciones"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111350_bb0145","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/adb.12408","article-title":"Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinence","volume":"22","author":"Garcia-Marchena","year":"2017","journal-title":"Addict. Biol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111350_bb0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-8993(02)03344-9","article-title":"Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine","volume":"954","author":"Gonz\u00e1lez","year":"2002","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111350_bb0155","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1176\/ajp.153.9.1195","article-title":"Psychiatric research interview for substance and mental disorders (PRISM): reliability for substance abusers","volume":"153","author":"Hasin","year":"1996","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111350_bb0160","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/jnc.13776","article-title":"Heterologous regulation of the cannabinoid type 1 receptor by angiotensin II in astrocytes of spontaneously hypertensive rats","volume":"139","author":"Haspula","year":"2016","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111350_bb0165","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pnpbp.2025.111350_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175669","article-title":"Endocannabinoid system as a therapeutic target for psychostimulants relapse: a systematic review of preclinical studies","volume":"951","author":"Karimi-Haghighi","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111350_bb0175","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/npr2.12312","article-title":"Attention-deficit hyperactivity symptoms and risk of alcohol use relapse","volume":"43","author":"Kawata","year":"2023","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.pnpbp.2025.111350_bb0180","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fnmol.2020.00125","article-title":"Cannabinoids, endocannabinoids and sleep","volume":"13","author":"Kesner","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111350_bb0185","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.ALC.0000057122.36127.C2","article-title":"Alcoholism: allostasis and beyond","volume":"27","author":"Koob","year":"2003","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111350_bb0190","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.cpr.2011.01.006","article-title":"Prospective association of childhood attention-deficit\/hyperactivity disorder (ADHD) and substance use and abuse\/dependence: a meta-analytic review","volume":"31","author":"Lee","year":"2011","journal-title":"Clin. Psychol. Rev."},{"issue":"12","key":"10.1016\/j.pnpbp.2025.111350_bb0195","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/ejn.14348","article-title":"Caffeine and cannabinoid receptors modulate impulsive behavior in an animal model of attentional deficit and hyperactivity disorder","volume":"49","author":"Leffa","year":"2019","journal-title":"Eur. J. Neurosci."},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111350_bb0200","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.3390\/ijerph17072610","article-title":"Substance abuse and public health: a multilevel perspective and multiple responses","volume":"17","author":"Lo","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"10","key":"10.1016\/j.pnpbp.2025.111350_bb0205","first-page":"1363","article-title":"The circulating and central endocannabinoid system in obesity and weight loss","volume":"48","author":"Mattelaer","year":"2024","journal-title":"Int. J. Obes."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111350_bb0210","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/1087054711427400","article-title":"Are some individuals diagnosed with ADHD prone to alcohol abuse? Consideration of two possible mediating factors for this susceptibility","volume":"17","author":"Maxwell","year":"2013","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.pnpbp.2025.111350_bb0215","first-page":"315","article-title":"Endocannabinoid system components as potential biomarkers in psychiatry","volume":"11","author":"Navarrete","year":"2020","journal-title":"Front. Psychol."},{"key":"10.1016\/j.pnpbp.2025.111350_bb0220","series-title":"Global Status Report on Alcohol and Health 2018","author":"OMS","year":"2019"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111350_bb0225","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1194\/jlr.D043794","article-title":"Analysis of ECs and related compounds in plasma: Artifactual isomerization and ex vivo enzymatic generation of 2-MGs","volume":"55","author":"Pastor","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.pnpbp.2025.111350_bb0230","first-page":"17","article-title":"Sex differences in psychiatric comorbidity and plasma biomarkers for cocaine addiction in abstinent cocaine-addicted subjects in outpatient settings","volume":"6","author":"Pedraz","year":"2015","journal-title":"Front. Psychol."},{"issue":"12","key":"10.1016\/j.pnpbp.2025.111350_bb0240","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archpsyc.1988.01800360017003","article-title":"The composite international diagnostic interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures","volume":"45","author":"Robins","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"issue":"s1","key":"10.1016\/j.pnpbp.2025.111350_bb0245","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1360-0443.2006.01592.x","article-title":"Comorbidity between substance use disorders and psychiatric conditions","volume":"101","author":"Schuckit","year":"2006","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111350_bb0250","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1521-0391.2012.12000.x","article-title":"Association between craving and attention deficit\/hyperactivity disorder symptoms among patients with alcohol use disorders","volume":"22","author":"Seitz","year":"2013","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.pnpbp.2025.111350_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109548","article-title":"Endocannabinoid-dependent decrease of GABAergic transmission on dopaminergic neurons is associated with susceptibility to cocaine stimulant effects in pre-adolescent male MAOA hypomorphic mice exposed to early life stress","volume":"233","author":"Serra","year":"2023","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111350_bb0260","doi-asserted-by":"crossref","first-page":"09","DOI":"10.35946\/arcr.v42.1.09","article-title":"Alcohol-endocannabinoid interactions: implications for addiction-related behavioral processes","volume":"42","author":"Serrano","year":"2022","journal-title":"Alcohol Res."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111350_bb0265","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.pharmthera.2011.06.005","article-title":"Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors","volume":"132","author":"Serrano","year":"2011","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111350_bb0270","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111350_bb0275","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1007\/s00394-021-02538-8","article-title":"Mediterranean diet consumption affects the endocannabinoid system in overweight and obese subjects: possible links with gut microbiome, insulin resistance and inflammation","volume":"60","author":"Tagliamonte","year":"2021","journal-title":"Eur. J. Nutr."},{"issue":"14","key":"10.1016\/j.pnpbp.2025.111350_bb0280","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1007\/s00018-014-1575-6","article-title":"Physical activity and the endocannabinoid system: an overview","volume":"71","author":"Tantimonaco","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.pnpbp.2025.111350_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v106.i01","article-title":"Elastic net regularization paths for all generalized linear models","volume":"106","author":"Tay","year":"2023","journal-title":"J. Stat. Softw."},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111350_bb0290","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1176\/appi.ajp.161.7.1231","article-title":"Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the psychiatric research interview for substance and mental disorders and the structured clinical interview for DSM-IV","volume":"161","author":"Torrens","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111350_bb0295","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1097\/MS9.0000000000002272","article-title":"Patterns of substance use and initiation timing in adults with substance abuse: a comparison between those with and without attention deficit hyperactivity disorder","volume":"86","author":"Vaziri-Harami","year":"2024","journal-title":"Ann. Med. Surg."},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111350_bb0300","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jpsychires.2009.11.013","article-title":"Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides","volume":"44","author":"Vinod","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2025.111350_bb0305","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/7854_2010_114","article-title":"Sexual differentiation of the brain and ADHD: what is a sex difference in prevalence telling us?","volume":"9","author":"Waddell","year":"2012","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111350_bb0310","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/acer.14659","article-title":"Persistent attention-deficit\/hyperactivity disorder predicts socially oriented, but not physical\/physiologically oriented, alcohol problems in early adulthood","volume":"45","author":"Wang","year":"2021","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.pnpbp.2025.111350_bb0315","series-title":"World Drugs Reports (s. f.)","author":"WDR","year":"2021"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625001046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625001046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T19:24:35Z","timestamp":1762284275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584625001046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":62,"alternative-id":["S0278584625001046"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111350","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploratory study on plasma Acylglycerol and Acylethanolamide dysregulation in substance use and attention-deficit\/hyperactivity disorder: Implications for novel biomarkers in dual diagnosis","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111350"}}